Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in Patients With Parkinson’s Disease

2014 ◽  
Vol 28 (2) ◽  
pp. 333-343 ◽  
Author(s):  
Betul Ozdilek ◽  
Gulay Kenangil
2014 ◽  
Vol 2 (2) ◽  
pp. 44-49 ◽  
Author(s):  
Kouichi Ohta ◽  
Takashi Osada ◽  
Yukito Shinohara ◽  
Norihiro Suzuki ◽  
Kazushi Takahashi ◽  
...  

2019 ◽  
Vol 13 (1) ◽  
pp. 78-81 ◽  
Author(s):  
Krisly Arguedas Vásquez ◽  
Erick Miranda Valverde ◽  
Daniel Valerio Aguilar ◽  
Henri-Jacques Hernández Gabarain

ABSTRACT. Several screening tests have been used for cognitive evaluation in Parkinson’s disease (PD). Objective: To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease and no cognitive impairment complaints. Methods: A total of 40 PD patients with no complaints of cognitive problems were included. Patients were selected using the Mini-Mental State Examination (MMSE) and the MoCA was then administered. Results: 80% of patients exhibited Mild Cognitive Impairment (MCI) according to the MoCA. Statistically significant differences in visuospatial, attention and delayed recall functions were evident between the normal and abnormal MoCA groups. Conclusion: The study results suggest that MoCA may be a good screening test in patients with PD who do not present cognitive complaints.


2018 ◽  
Vol 265 (9) ◽  
pp. 1976-1984 ◽  
Author(s):  
Patricia Sulzer ◽  
Sara Becker ◽  
Walter Maetzler ◽  
Elke Kalbe ◽  
Luc van Nueten ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document